MolnupiravirLack of efficacy and off-label use

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2005卷 / 1期

关键词：

D O I：

10.1007/s40278-024-57639-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：546 / 546

相关论文

共 50 条

[31] Off-label use of antipsychotics: Rethinking "off-label"
Groleger, Urban
PSYCHIATRIA DANUBINA, 2007, 19 (04) : 350 - 353
[32] Mepolizumab/omalizumabLack of efficacy following off-label use
Reactions Weekly, 2024, 1998 (1) : 296 - 296
[33] AntineoplasticsLack of efficacy and off-label use: case report
Reactions Weekly, 2021, 1866 (1) : 47 - 47
[34] Quality, Safety and Efficacy in the 'Off-Label' Use of Medicines
Kairuz, Therese Eileen
Gargiulo, Derryn
Bunt, Craig
Garg, Sanjay
CURRENT DRUG SAFETY, 2007, 2 (01) : 89 - 95
[35] AdalimumabLack of efficacy and off-label use: case reports
Reactions Weekly, 2023, 1972 (1) : 19 - 19
[36] BevacizumabLack of efficacy and off-label use: case report
Reactions Weekly, 2025, 2042 (1) : 81 - 81
[37] AcetylcysteineLack of efficacy and off-label use: case report
Reactions Weekly, 2022, 1900 (1) : 16 - 16
[38] AntineoplasticsLack of efficacy and off-label use: case report
Reactions Weekly, 2021, 1838 (1) : 56 - 56
[39] DexamethasoneLack of efficacy and off-label use: case report
Reactions Weekly, 2022, 1910 (1) : 178 - 178
[40] Nirmatrelvir+ritonavirLack of efficacy and off-label use
Reactions Weekly, 2024, 2002 (1) : 375 - 375

← 1 2 3 4 5 →